Special Issue "AIDS Vaccine 2014"
Deadline for manuscript submissions: closed (15 July 2014)
A few decades after the discovery of human immunodeficiency viruses as the causal pathogens for AIDS, an effective AIDS vaccine has not been successfully developed to curb the global epidemic of HIV infections. HIV employs many tactics to prevent induction of protective T and B cell immune responses. Facing such a huge challenge, we hope this "AIDS Vaccine" special issue will offer a platform for publication of cutting-edge results in the AIDS vaccine research field.
Previous Special Issue published in Viruses: "AIDS Vaccine"
Prof. Dr. Feng Gao
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed Open Access monthly journal published by MDPI.
- cell mediated immune response
- genetic variation